Caricamento...
The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients
BACKGROUND: There has been debate on the use of angiotensin-converting enzyme‑2 (ACE2) expression mediating pharmacotherapy in COVID-19 infected patients. Although it has been suggested that these drugs might lead to a higher susceptibility and severity of COVID-19 infection, experimental data sugge...
Salvato in:
| Pubblicato in: | Neth Heart J |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bohn Stafleu van Loghum
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8050813/ https://ncbi.nlm.nih.gov/pubmed/33860910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-021-01573-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|